L
4.44
0.01 (0.34%)
| Penutupan Terdahulu | 4.42 |
| Buka | 4.50 |
| Jumlah Dagangan | 22,159 |
| Purata Dagangan (3B) | 198,401 |
| Modal Pasaran | 166,354,224 |
| Harga / Pendapatan (P/E Ke hadapan) | 8.67 |
| Harga / Jualan (P/S) | 1.18 |
| Harga / Buku (P/B) | 197.99 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Aug 2026 |
| Margin Keuntungan | -34.27% |
| Margin Operasi (TTM) | -6.52% |
| EPS Cair (TTM) | -1.47 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -1.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 274.83% |
| Nisbah Semasa (MRQ) | 2.71 |
| Aliran Tunai Operasi (OCF TTM) | 2.69 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -27.28 M |
| Pulangan Atas Aset (ROA TTM) | -3.11% |
| Pulangan Atas Ekuiti (ROE TTM) | -83.58% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Lifecore Biomedical, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
-1.0
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | -2.5 |
| Purata | -1.00 |
|
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 2.06% |
| % Dimiliki oleh Institusi | 72.40% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Legion Partners Asset Management, Llc | 31 Mar 2026 | 4,461,823 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |